JAMA & ARCHIVES
Arch Fam Med
SEARCH
GO TO ADVANCED SEARCH
HOME  PAST ISSUES  TOPIC COLLECTIONS  CME  PHYSICIAN JOBS  CONTACT US  HELP
Institution: STANFORD Univ Med Center  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 2 No. 8, August 1993 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Multicenter Comparison of Clarithromycin and Amoxicillin in the Treatment of Acute Maxillary Sinusitis

Karen Hall Calhoun, MD; James A. Hokanson, PhD

Arch Fam Med. 1993;2(8):837-840.


Abstract

Purpose
To compare the safety and efficacy of orally administered clarithromycin, a new macrolide antimicrobial, and amoxicillin in the treatment of patients with acute maxillary sinusitis.

Patients and Methods
One hundred forty-two consecutive outpatients treated at four primary care centers for acute maxillary sinusitis were randomly assigned to receive oral clarithromycin (500 mg twice daily) or oral amoxicillin (500 mg three times daily) for 7 to 14 days. Clinical and roentgenographic responses to the antibiotic therapy were determined within 48 hours after the last dose and 6 weeks later.

Results
The success rates of clarithromycin and amoxicillin were comparable. A clinical success rate of 91% and a roentgenographic success rate of 78% were achieved in the clarithromycin group at the final visit; comparable results for the amoxicillin group were 89% and 92%, respectively. Differences between the two groups were not statistically significant (P=.766 and .064, respectively). No serious adverse events were reported, although both drugs caused mild gastrointestinal distress. Dropout rates were low in both groups: 3% for clarithromycin and 4% for amoxicillin. No clinically significant changes in laboratory studies were observed in either group.

Conclusion
Clarithromycin twice daily is effective and well tolerated in patients with acute maxillary sinusitis.



Author Affiliations

From the Departments of Otolaryngology (Drs Calhoun and Hokanson), Preventive Medicine and Community Health, and Internal Medicine (Dr Hokanson), University of Texas Medical Branch, Galveston.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Management of Acute and Chronic Sinusitis in Adult Patients
Conry and Castanheira
Journal of Pharmacy Practice 2003;16:335-348.
ABSTRACT  

The Question of Clarithromycin: A First-Line Drug for Sinusitis?
Tahara et al.
Arch Fam Med 1994;3:574-574.
ABSTRACT  

Multicenter Comparison of Clarithromycin and Amoxicillin-Reply
Calhoun
Arch Fam Med 1994;3:575-575.
ABSTRACT  

Empiric Antibiotics in Sinusitis
Geraci
Arch Fam Med 1994;3:573-573.
ABSTRACT  

Multicenter Comparison of Clarithromycin and Amoxicillin
Rust
Arch Fam Med 1994;3:574-575.
ABSTRACT  




HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1993 American Medical Association. All Rights Reserved.